CBS 2019
CBSMD教育中心
中 文

Cardio-Oncology

Abstract

Recommended Article

Abnormalities in 3-Dimensional Left Ventricular Mechanics With Anthracycline Chemotherapy Are Associated With Systolic and Diastolic Dysfunction Apixaban to Prevent Venous Thromboembolism in Patients with Cancer Cardiac Metastases in Patients with Neuroendocrine Tumours: Clinical Features, Therapy Outcomes, and Prognostic Implications Cardiotoxicity and Cardiac Monitoring Among Chemotherapy-Treated Breast Cancer Patients Longitudinal Assessment of Vascular Function With Sunitinib in Patients With Metastatic Renal Cell Carcinoma Cardiovascular effects of radiation therapy Cardio-Oncology Services: rationale, organization, and implementation: A report from the ESC Cardio-Oncology council ACS Management in a Patient in Need of Noncardiac Surgery

Clinical Trial2016 Jul;31(3):196-209.

JOURNAL:Cardiovasc Interv Ther. Article Link

One-year outcome of a prospective trial stopping dual antiplatelet therapy at 3 months after everolimus-eluting cobalt-chromium stent implantation: ShortT and OPtimal duration of Dual AntiPlatelet Therapy after everolimus-eluting cobalt-chromium stent (STOPDAPT) trial

Natsuaki M, Morimoto T, Kimura T et al. Keywords: Coronary artery disease; Coronary stent; Dual antiplatelet therapy; Everolimus-eluting stent

FULL TEXT PDF